Neonatal screening for congenital adrenal hyperplasia;Triagem neonatal para hiperplasia adrenal congênita

Revista da Associacao Medica Brasileira

Volumn 58, Issue 4, 2012, Pages 459-464

  Barra, Cristina Botelho ^a   Silva, Ivani Novato ^a,b   Pezzuti, Isabela Leite ^a   Januário, José Nélio ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FMUFMG   (Brazil)

Author keywords

Congenital adrenal hyperplasia; Early diagnosis; Neonatal screening

Indexed keywords

EID: 84866065745     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302012000400017     Document Type: Article

References (32)

1. Leão LL, Aguiar MJ. Newborn screening: what pediatricians should know. J Pediatr (Rio J.). 2008;84(Suppl 4):S80-90.
2. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO; 1968. Public Health Papers, 34. Disponível em: http://www.who.int/bulletin/volumes/86/4/07-050112BP.pdf.
3. White PC. Neonatal screening for congenital adrenal hyperplasia. Nat Rev Endocrinol. 2009;5:490-8.
4. Honour JW, Torresani, T. Evaluation of Neonatal Screening for Congenital Adrenal Hyperplasia. Horm Res. 2001;55:206-11.
5. van der Kamp HJ, Wit JM. Neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol. 2004;151(Suppl):U71-5.
6. Ballerini MG, Chiesa A, Scaglia P, Gruñeiro-Papendieck L, Heinrich JJ, Ropelato MG. 17alpha-hydroxyprogesterone and cortisol serum in neonates and young children: influence of age, gender and methodological procedures. J Pediatr Endocrinol Metab. 2010;23:121-32.
7. Olgemöller B, Roscher AA, Liebl B, Fingerhut R. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab. 2003;88:5790-4.
8. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr. 1997;130:128-33.
9. National Newborn Screening Information System 2009. Disorder Report for Congenital Adrenal Hyperplasia (CAH). Available from: http://www2.uthscsa.edu/nnsis/.
10. Papendieck LG, Prieto L, Chiesa A, Bengolea S, Bergadá C. Congenital hyperplasia and early newborn screening: 17 alpha-hydroxyprogesterone (17 alpha--OHP) during the first days of life. J Med Screen. 1998;5:24-6.
11. Triagem neonatal. Disponível em: http://www.nupad.medicina.ufmg.br.
12. Yoo, BK, Grosse SD. The cost effectiveness of screening newborns for congenital adrenal hyperplasia. Public Health Genomics. 2009;12:67-72.
13. Waisbren SE, Albers S, Amato S, Ampola M, Brewster TG, Demmer L et al. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA. 2003;290:2564-72.
14. Gruñieiro-Papendieck L, Chiesa A, Mendez V, Prieto L. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina. J Pediatr Endocrinol Metab. 2008;21:73-8.
15. Silveira EL, Santos EP, Bachega TA, van der Linden Nader I, Gross JL, Elnecave RH. The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred-an estimate based on a public neonatal screening program in the state of Goiás. J Pediatr Endocrinol Metab. 2008;21:455-60.
16. Souza CF, Schwartz IV, Giugliani R. Triagem neonatal de distúrbios metabólicos. Ciênc Saúde Coletiva. 2002;7:129-37.
17. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Especializada. Manual de normas técnicas e rotinas operacionais do programa nacional de triagem neonatal/Brasil. 2a ed. Brasília (DF): Ministério da Saúde; 2005.
18. American College of Medical Genetics. Maternal and Child Health Bureau. Health Resources and Services Administration. US Department of Health and Human Services. Newborn screening: toward a uniform screening panel and system. 2005. Disponível em: http://www.acmg.net//AM/Template.cfm?Section=Home3.
19. Carvalho TM, Santos HP, Santos IC, Vargas PR, Pedrosa J. Newborn screening: a national public health programme in Brazil. J Inherit Metab Dis. 2007;30:615.
20. Programa Nacional de Triagem Neonatal. Disponível em: http://portal.saude.gov.br/portal/saude/area.cfm?id_area=1061.
21. Pang S, Hotchkiss J, Drash AL, Levine LS, New MI. Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1977;45:1003-8.
22. Caulfield MP, Lynn T, Gottschalk ME, Jones KL, Taylor NF, Malunowicz EM et al. The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine speciemens. J Clin Endocrinol Metab. 2002;87:3682-90.
23. Maeda M, Arakawa H, Tsuji A, Yamagami Y, Isozaki A, Takahashi T et al. Enzyme-linked immunosorbent assay for 17-hydroxyprogesterone in dried blood spotted on filter paper. Clin Chem. 1987;33:761-4.
24. González EC, Marrero N, Pérez PL, Frómeta A, Zulueta O, Herrera D et al. An Enzyme immunoassay for determining 17 alpha-hydroxyprogesterone in dried blood spots on filter paper using an ultramicroanalytical system. Clin Chim Acta. 2008;394:63-6.
25. Chu SY, Tsai WY, Chen LH, Wei ML, Chien YH, Hwu WL. Neonatal screening for congenital adrenal hyperplasia in Taiwan: a pilot study. J Formos Med Assoc. 2002;101:691-4.
26. Fingerhut R. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17-alpha-hydroxyprogesterone (17-OHP) values. Steroids. 2009;74:662-5.
27. Gurian EA, Kinnamon DD, Henry JJ, Waisbren SE. Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics. 2006;117:1915-21.
28. Rugolo LM. Growth and developmental outcomes of the extremely preterm infant. J Pediatr (Rio J). 2005;81(Suppl 1):S101-10.
29. Pollit RJ. International perspectives on newborn screening. J Inherit Metab Dis. 2006;29:390-6.
30. Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008;86:317-9. Disponível em:http://www.who.int/bulletin/volumes/86/4/07-050112/en/index.html.
31. Gruñeiro-Papendieck L, Prieto L, Chiesa A, Bengolea S, Bossi G, Bergadá C. Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol. Horm Res. 2001;55:271-7.
32. Brasil. Ministério da Saúde. Audiência pública para discutir os avanços e possibilidades do Teste do Pezinho. Disponível em: http://www.senado.gov.br/noticias/tv/programaListaPadrao.asp?COD_VIDEO=86302.